Aquestive Therapeutics, Inc.·4

Aug 9, 4:30 PM ET

Kraus Carl N 4

4 · Aquestive Therapeutics, Inc. · Filed Aug 9, 2023

Insider Transaction Report

Form 4
Period: 2023-08-09
Kraus Carl N
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-08-09+150,000150,000 total
Footnotes (1)
  • [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment

Documents

1 file
  • 4
    marketforms-62126.xmlPrimary

    PRIMARY DOCUMENT